Delivery Order SPE2D020D0009-SPE2D325F0802

Award Date 10/23/24
Potential Completion Date 10/28/24
Potential Value $88K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $9,692.20, is a delivery order for the supply of 4,566,185,312 units of Vancomycin 1 gram vials. The contract has an ultimate completion date of October 28, 2024, and is a firm fixed-price contract. Fresenius Kabi, LLC is a significant supplier of critical care...
This federal contract award, valued at $39,653.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of 4,566,185,310 vials of the antibiotic drug vancomycin 1 gram, which is a critical medical treatment for military and federal healthcare facilities. The contract has an ultimate completion date of October 28, 2024, and is structured as a firm fixed-price...
This federal contract award, identified as SPE2D020D0009|SPE2D325F0805, was issued by the Defense Logistics Agency (DLA) to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $14,074.76 Firm Fixed Price Delivery Order contract is for the supply of 4,566,185,308 units of Vancomycin 1 GM Vials, a critical care pharmaceutical product used by military and federal healthcare facilities. The contract has an ultimate completion date of October...
This is a delivery order contract awarded to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $42,434.98, is for the delivery of Vancomycin 1 gram vials to federal government agencies. The contract is a firm fixed-price delivery order with an ultimate completion date of October 28, 2024. Fresenius Kabi is a significant supplier of critical care pharmaceuticals, focusing primarily...
This federal contract award, SPE2D020D0009|SPE2D323F9771, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of VANCOMYCIN 1 GM VIALS, a critical care injectable medication, with a ceiling value of $78,482.57 and a completion date of June 6, 2023. The contract is structured as a Firm Fixed Price Delivery Order and does not have a...
This federal contract award, with ID SPE2D020D0009|SPE2D325F0800, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of 4,566,185,313 units of vancomycin 1 gram vials, a critical care pharmaceutical used in military and federal healthcare facilities. The contract has a firm fixed price pricing type, a ceiling value of $24,019.80,...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical, a subordinate command of the Department of Defense, to Fresenius Kabi USA, LLC, a foreign-owned pharmaceutical company. The contract is for the delivery of 1 gram vials of vancomycin hydrochloride, an injectable antibiotic, with a ceiling value of $271,291.92 and a period of performance ending on March 31, 2016. The contract was awarded on September 24, 2015 and does not carry a...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company. The contract, valued at $41,636,277.00, is for the delivery of pharmaceutical and medical supplies, with no set-aside designation. The contract is structured as a firm fixed-price, delivery order arrangement to support medical facilities worldwide, particularly for the Department of Defense...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide VANCOMYCIN HCL 2 GRAM VIALS. The contract has a firm fixed price of $2,876.89 and a completion date of May 19, 2025. The contract is not set aside and is a part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides comprehensive global pharmaceutical support to...
This is a $5,380.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,671,859 units of Vancomycin HCl 2 gram vials, a critical pharmaceutical product used in medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
  • SPE2D020D0009
    Indefinite Delivery Contract
  • SPE2D020D0009-SPE2D325F0802
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $87,819.76, is for the supply of 4,566,185,311 vials of the antibiotic Vancomycin 1 gram. The contract has an ultimate completion date of October 28, 2024. Fresenius Kabi, LLC is a significant supplier of critical care pharmaceuticals, injectable medications, and medical solutions to various federal government agencies, including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. This contract is not set aside and is part of the company's broader Indefinite Delivery Contract (IDC) with the National Acquisition Center of the Department of Veterans Affairs, valued at $2,237,072.60, for the supply of Bortezomib, a cancer treatment drug.

Generated 5/25/25, 9:46 AM